LSTM Home > LSTM Research > LSTM Online Archive

P4-mediated antibody therapy in an acute model of invasive pneumococcal disease

Bangert, Mathieu, Gordon, Stephen ORCID: https://orcid.org/0000-0001-6576-1116, Bricio-Moreno, Laura, Gore, Suzanna, Rajam, Gowrisankar, Ades, Edwin and Kadioglu, Aras (2012) 'P4-mediated antibody therapy in an acute model of invasive pneumococcal disease'. Journal of Infectious Disease, Vol 205, Issue 9, pp. 1399-1402.

Full text not available from this repository.

Abstract

New treatments against severe bacterial infections are needed because the response to antibiotic treatment is slow in acute settings and is becoming less effective owing to the emergence of antibiotic-resistant pathogens. P4-mediated antibody therapy offers a unique treatment strategy that combines exogenous immunoglobulin with the immunoactivating peptide P4. In an acute model of pneumococcal disease, mice were infected with Streptococcus pneumoniae and treated intravenously or intranasally with P4 and intravenous immunoglobulin (IVIG). Survival of P4-IVIG-treated mice increased from 0% to 60% among those that received intravenous treatment and from 0% to 100% among those that received intranasal treatment. Importantly, intranasal administration of P4 at an early stage of infection prevented the onset of bacteremia and sepsis. Increased survival was associated with reduced bacterial burden in affected tissues and with recruitment and activation of professional phagocytes, as manifested by increased expression of Fc-γ receptors. In vitro studies involving P4-stimulated alveolar, peritoneal, and J774.2 murine macrophages showed an increased ability of these immune cells to phagocytose pneumococci independent of capsule. The use of adjunct antibody therapies to treat infectious diseases shows promise.

Item Type: Article
Subjects: QV Pharmacology > QV 38 Drug action.
QW Microbiology and Immunology > QW 45 Microbial drug resistance. General or not elsewhere classified.
QW Microbiology and Immunology > Immune Responses > QW 700 Infection. Mechanisms of infection and resistance.
WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 200 Bacterial infections (General or not elsewhere classified)
WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 217 Pneumococcal infections
Digital Object Identifer (DOI): https://doi.org/10.1093/infdis/jis223
Depositing User: Users 379 not found.
Date Deposited: 24 Sep 2012 11:10
Last Modified: 07 Dec 2018 10:09
URI: http://archive.lstmed.ac.uk/id/eprint/3015

Statistics

View details

Actions (login required)

Edit Item Edit Item